Showing results (91-100 of 180) with videos related to

Sort By:
Pageof 18
Clinical Toxicology (Philadelphia, Pa.)|March 17, 2026
Lamotrigine-induced Stevens-Johnson syndrome: a systematic review of case reports and case seriesAnkita Saxena, Vaibhav Chaudhary, Sweta Kumari, et al.
Plos Neglected Tropical Diseases|February 2, 2016
Induction of IL-10 and TGFβ from CD4+CD25+FoxP3+ T Cells Correlates with Parasite Load in Indian Kala-azar Patients Infected with Leishmania donovaniPradyot Bhattacharya, Smriti Ghosh, Sarfaraz Ahmad Ejazi, et al.
Immunology and Cell Biology|October 5, 2011
TGF-β1 re-programs TLR4 signaling in L. donovani infection: enhancement of SHP-1 and ubiquitin-editing enzyme A20Sushmita Das, Krishna Pandey, Ashish Kumar, et al.
Antimicrobial Agents and Chemotherapy|November 30, 2011
Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovaniBidyut Purkait, Ashish Kumar, Nilay Nandi, et al.
Plos Neglected Tropical Diseases|September 19, 2014
Efficacy and safety of amphotericin B emulsion versus liposomal formulation in Indian patients with visceral leishmaniasis: a randomized, open-label studyShyam Sundar, Krishna Pandey, Chandreshwar Prasad Thakur, et al.
Plos Neglected Tropical Diseases|October 25, 2016
Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort StudySushmita Das, Rakesh Mandal, Vidya Nand Rabidas, et al.
The American Journal of Tropical Medicine and Hygiene|September 21, 2016
Pharmacovigilance of Miltefosine in Treatment of Visceral Leishmaniasis in Endemic Areas of Bihar, IndiaKrishna Pandey, Vidyanand Ravidas, Niyamat A Siddiqui, et al.
Parasitology International|September 17, 2014
Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasisPranati Das, Ajay Amit, Shubhankar Kumar Singh, et al.
Pageof 18